$0.1800
-0.0869-32.56%
Last update: Oct 6, 2:43 PM
EFFECTOR THERAPUTCS INC by eFFECTOR Therapeutics, Inc.
EFTROTCEM
EFFECTOR THERAPUTCS INC by eFFECTOR Therapeutics, Inc. (EFTR) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-2.16 | $-1.65 | $-3.00 | $-5.00 |
| Actual | $-2.16 | $-3.42 | $-3.25 | $-4.25 |
| Surprise | 0.00% | -107.3% | -8.33% | +15.0% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q1 | May 9, 2024 | $-2.16 | $-2.16 | 0.00 % |
| Q4 | Mar 25, 2024 | $-3.42 | $-1.65 | -107.3 % |
| Q3 | Nov 13, 2023 | $-3.25 | $-3.00 | -8.33 % |
| Q2 | Aug 8, 2023 | $-4.25 | $-5.00 | 15.0 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | Mar 8, 2023 | $674.00K | $660.00K | 2.12 % |
| Q3 | Nov 7, 2022 | $867.00K | $640.00K | 35.5 % |
| Q2 | Aug 9, 2022 | $2.01M | $520.00K | 286.7 % |
| Q1 | May 10, 2022 | $0 | $350.00K | -100.0 % |
